Blockchain Platform Kaleido Expands Into Asia Pacificbr>
Blockhain platform Kaleido has announced that it will be expanding its Blockchain Business Cloud in the Asia Pacific (APAC) region to meet surging demand for blockchain solutions among enterprises and governments.
Launched in May of this year by ConsenSys in collaboration with Amazon Web Services, Kaleido is a software-as-a-service (SaaS) platform that radically simplifies deployment and operation of secure private chains. The ethereum-based platform was designed to greatly simplify and accelerate blockchain adoption from experimentation to implementation. The platform allows organizations to choose between the Quorum and Geth protocol packages, and different consensus algorithms such as RAFT, IBFT and POA.
According to its latest announcment, Kaleido is expanding to the AWS data centers in Asia Pacific (Sydney) and Asia Pacific (Seoul) regions, with several others planned in coming months. The objective of the expansion is to empower APAC businesses to accelerate their transformation through the use of blockchain technology.
“Serious investment in enterprise blockchain initiatives across Asia Pacific is off the charts,” said Joe Lubin, Co-Founder of Ethereum and CEO of ConsenSys. “Building on our partnership and the significant regional presence with AWS, Kaleido and ConsenSys Solutions APAC are meeting this demand and are well poised to scale and grow quickly throughout the region.”
The Kaleido APAC expansion has already attracted the attention of Shanghai-based genome data sequencing and analytics firm Caifeng Gene. It will be using the Kaleido platform to provide a breakthrough permissioned data exchange. Caifeng Gene will initially focus on improving early diabetes detection, prevention, and management, which already affects over 110 million patients in China and nearly 10 percent of the adult population.
Caifeng Gene will also utilize the platform to build a consortium around Diabetes Reference Cohort data as well as patient diagnostic data. The consortium will include hospitals, genome sequencing service providers, biotech, and pharmaceutical companies. The Kaleido platform will allow consortium members to securely and efficiently share medical records, lab data, genotype data from microarrays, and DNA data from Next-Generation Sequencing (NGS), in order to develop evidence-based treatment plans tailored to each individual patient, while ensuring personal privacy.
Caifeng Gene CEO Lifeng Tian said that the goal is to empower individuals to protect, share and monetize their own data and transact with pharma and biotech companies that are looking to harness that data for medical research and development.
“With Kaleido we have found a renowned partner and a proven platform to help deliver and accelerate blockchain-based data sovereignty and permissioned exchange scenarios,” said Tian. “This will ultimately lead to faster diabetes medical discoveries through precise diagnosis and can therefore dramatically improve the public health of this particular population.”
The Kaleido platform is also currently being used by rural banks in the Philippines under the Project i2i. The project allows rural banks to do real-time funds transfers between banks, domestic and international. The project also enables banks and the customers to have access to universal banking products and share their own services on the platform.
“Inter-bank transactions can take up to a month, however Project i2i’s blockchain-based payment network enabled by the Kaleido platform can reduce this to less than five minutes and eliminates the need for paper-based record keeping and manual transactions,” Kaleido said.